Search

Your search keyword '"Pier Luigi, Filosso"' showing total 228 results

Search Constraints

Start Over You searched for: Author "Pier Luigi, Filosso" Remove constraint Author: "Pier Luigi, Filosso"
228 results on '"Pier Luigi, Filosso"'

Search Results

1. Prognostic Thresholds of Mitotic Count and Ki-67 Labeling Index for Recurrence and Survival in Lung Atypical Carcinoids

2. The Role of Lymphadenectomy in Early-Stage NSCLC

3. Recurrence-Free Survival in Early and Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung after Complete Tumor Resection

4. External Validation of a Prognostic Score for Survival in Lung Carcinoids

5. The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: Unresolved Issues to be Addressed for the Next Ninth Edition of the TNM Classification of Malignant Tumors

6. Comparison Between Electronic and Traditional Chest Drainage Systems: A Multicenter Randomized Study

7. Survival Analysis in Single N2 Station Lung Adenocarcinoma: The Prognostic Role of Involved Lymph Nodes and Adjuvant Therapy

8. The International Thymic Malignancy Interest Group Classification of Thymoma Recurrence: Survival Analysis and Perspectives

9. Molecular Genomic Assessment Using a Blood-based mRNA Signature (NETest) is Cost-effective and Predicts Neuroendocrine Tumor Recurrence With 94% Accuracy

11. Accuracy of F-18-FDG in Detecting Stage I Lung Adenocarcinomas According to IASLC/ATS/ERS Classification

12. Intraoperative near-infrared molecular imaging for diagnostic thoracoscopy in difficult clinical scenario

13. The Influence of Tissue Ischemia Time on RNA Integrity and Patient-Derived Xenografts (PDX) Engraftment Rate in a Non-Small Cell Lung Cancer (NSCLC) Biobank.

14. External validation of the N descriptor in the proposed tumour–node–metastasis subclassification for lung cancer: the crucial role of histological type, number of resected nodes and adjuvant therapy

15. The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non–Small Cell Lung Cancer

16. IL-17 Promotes Nitric Oxide Production in Non-Small-Cell Lung Cancer

17. Blood Chromogranin A Is Not Effective as a Biomarker for Diagnosis or Management of Bronchopulmonary Neuroendocrine Tumors/Neoplasms

18. NETest Liquid Biopsy Is Diagnostic of Lung Neuroendocrine Tumors and Identifies Progressive Disease

19. Survival Analysis in Single N2 Station Lung Adenocarcinoma: The Prognostic Role of Involved Lymph Nodes and Adjuvant Therapy

20. Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest)

21. Proctor-guided virtual reality-enhanced three-dimensional video-assisted thoracic surgery: an excellent tutoring model for lung segmentectomy

22. Thymomectomy plus total thymectomy versus simple thymomectomy for early-stage thymoma without myasthenia gravis: A European Society of Thoracic Surgeons Thymic Working Group Study

23. Corrigendum to 'Thymomectomy plus total thymectomy versus simple thymomectomy for early-stage thymoma without myasthenia gravis: a European Society of Thoracic Surgeons Thymic Working Group Study'

24. Clinicopathological features and current treatment outcomes of neuroendocrine thymic tumours

25. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study

26. Minimally invasive thymectomy for myasthenia gravis: The world seems to turn left

27. Primary Neuroendocrine Tumors of the Lung

28. Safety and Feasibility of Thoracic Malignancy Surgery During the COVID-19 Pandemic

29. Is %ΔSUVmax a Useful Indicator of Survival in Patients with Advanced Nonsmall-Cell Lung Cancer?

30. Accuracy of

31. Extent of resection and lymph node evaluation in early stage metachronous second primary lung cancer: a population-based study

32. The International Association for the Study of Lung Cancer Thymic Tumors Staging Project: The Impact of the Eighth Edition of the Union for International Cancer Control and American Joint Committee on Cancer TNM Stage Classification of Thymic Tumors

33. Analysis of pneumothorax recurrence risk factors in 843 patients who underwent videothoracoscopy for primary spontaneous pneumothorax: results of a multicentric study

34. Prognostic score for survival with pulmonary carcinoids: The importance of associating clinical with pathological characteristics

35. Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: a multicentre analysis†

36. Cell of origin markers identify different prognostic subgroups of lung adenocarcinoma

37. Molecular strategies in the management of bronchopulmonary and thymic neuroendocrine neoplasms

38. Post-operative NETest scores detect residual NET disease and accurately predicts tumor recurrence in R0

39. Pneumonectomy in bronchial carcinoid tumors

40. Commentary: Dangerous liaisons—Paraneoplastic syndromes and thymoma

41. Commentary: Robotic-Re-Thymectomy: A Surgical Effective Chance to Treat Refractory Myasthenia Gravis

42. Molecular identification of bronchopulmonary neuroendocrine tumours and neuroendocrine genotype in lung neoplasia using the NETest liquid biopsy

43. How should we manage the chest drainage after a video-assisted thoracoscopic surgery lobectomy?

44. Chest drain and thoracotomy for chest trauma

45. The reason for an idea

46. Risk of recurrence in stage I adenocarcinoma of the lung: A multi-institutional study on synergism between type of surgery and type of nodal staging

47. Prognostic factors after treatment for iterative thymoma recurrences: A multicentric experience

48. Large Cell Neuroendocrine Tumor Size >3 cm Negatively Impacts Long-Term Outcomes After R0 Resection

49. Sublobar Resection in the Treatment of Peripheral Typical Carcinoid Tumors of the Lung

50. Sleeve lobectomy compared with pneumonectomy for operable centrally located non-small cell lung cancer: A meta-analysis

Catalog

Books, media, physical & digital resources